Shi Liang

1.1k total citations
27 papers, 502 citations indexed

About

Shi Liang is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shi Liang has authored 27 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shi Liang's work include Cardiac Fibrosis and Remodeling (4 papers), RNA Interference and Gene Delivery (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Shi Liang is often cited by papers focused on Cardiac Fibrosis and Remodeling (4 papers), RNA Interference and Gene Delivery (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Shi Liang collaborates with scholars based in China, United States and Macao. Shi Liang's co-authors include Yandan Yao, Junmeng Zheng, Hongbin Gao, Lijuan Wen, Jiaqi Li, Xilong Wang, Baoyong Gong, Xiaolong Yuan, Wei Wu and Junxiong Qiu and has published in prestigious journals such as Nature Communications, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Shi Liang

26 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi Liang China 13 280 108 72 69 64 27 502
Yuanyuan Meng China 14 298 1.1× 196 1.8× 58 0.8× 33 0.5× 46 0.7× 37 599
Qing Yuan China 12 157 0.6× 90 0.8× 52 0.7× 25 0.4× 40 0.6× 42 391
Cheng Ni China 9 317 1.1× 169 1.6× 64 0.9× 25 0.4× 95 1.5× 15 494
Beibei Ni China 15 480 1.7× 186 1.7× 26 0.4× 44 0.6× 71 1.1× 33 740
Ke Yuan China 12 324 1.2× 223 2.1× 55 0.8× 20 0.3× 67 1.0× 65 670

Countries citing papers authored by Shi Liang

Since Specialization
Citations

This map shows the geographic impact of Shi Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Liang more than expected).

Fields of papers citing papers by Shi Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Liang. The network helps show where Shi Liang may publish in the future.

Co-authorship network of co-authors of Shi Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Liang. A scholar is included among the top collaborators of Shi Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Liang. Shi Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, P., Wei Liu, Yangfan Su, et al.. (2025). Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response. Frontiers in Pharmacology. 16. 1535703–1535703. 1 indexed citations
2.
Zhou, Jenny, Shi Liang, Ling Yin, et al.. (2025). Characterization of a novel conditional knockout mouse model to assess efficacy of mRNA therapy in the context of severe OTC deficiency. Molecular Therapy. 33(3). 1197–1212. 1 indexed citations
3.
4.
Hou, Lidan, Jie Zhao, Liuxin Cai, et al.. (2024). HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase. Journal of Medical Virology. 96(4). e29607–e29607. 1 indexed citations
5.
Wang, Haibin, et al.. (2024). RNA-seq Based Transcriptome Analysis Reveals Role of Myoglobin in Rheumatoid Arthritis. Inflammation. 48(4). 1745–1759. 1 indexed citations
6.
7.
Zheng, Shaoxin, Ling Li, Liu Liu, et al.. (2022). Changes in echocardiographic parameters of the donor’s heart before and after heart transplantation and their relationship with post-transplant survival. Annals of Translational Medicine. 10(6). 280–280. 2 indexed citations
8.
Fu, Yuan, Junxiong Qiu, Jianhua Wu, et al.. (2022). USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(5). 159258–159258. 11 indexed citations
9.
Liang, Shi, et al.. (2022). Epidemiology and survival of patients with malignant carotid body tumors in the SEER database. Journal of Vascular Surgery. 76(4). 973–978.e1. 8 indexed citations
10.
Lu, Liuyi, Junxiong Qiu, Chao Wang, et al.. (2022). ZBTB20 regulates cardiac allograft rejection through NFкB-mediated inflammation in mouse heart transplantation. Transplant Immunology. 74. 101676–101676. 5 indexed citations
11.
Gao, Hongbin, et al.. (2022). Alleviation of doxorubicin-induced cardiomyocyte death through miR-147-y-mediated mitophagy. Biochemical and Biophysical Research Communications. 609. 176–182. 8 indexed citations
12.
Qiu, Junxiong, Yuan Fu, Zhiteng Chen, et al.. (2021). BTK Promotes Atherosclerosis by Regulating Oxidative Stress, Mitochondrial Injury, and ER Stress of Macrophages. Oxidative Medicine and Cellular Longevity. 2021(1). 9972413–9972413. 24 indexed citations
13.
Tao, Jun, Junxiong Qiu, Liuyi Lu, et al.. (2021). ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox‐LDL‐Induced Macrophages in Atherosclerosis. Oxidative Medicine and Cellular Longevity. 2021(1). 5590855–5590855. 19 indexed citations
14.
Jiang, Lei, Ling Yin, Eric Jacquinet, et al.. (2020). Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia. Nature Communications. 11(1). 5339–5339. 91 indexed citations
15.
Yuan, Xiaolong, Lijuan Wen, Baoyong Gong, et al.. (2019). MiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN. Frontiers in Cell and Developmental Biology. 7. 249–249. 50 indexed citations
16.
Chao, Xue, Kai Chen, Jiayi Zeng, et al.. (2019). Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer. 19(1). 372–372. 52 indexed citations
17.
Liang, Shi, Junmeng Zheng, Wei Wu, et al.. (2018). A Robust Nanoparticle Platform for RNA Interference in Macrophages to Suppress Tumor Cell Migration. Frontiers in Pharmacology. 9. 1465–1465. 18 indexed citations
18.
Mao, Kai, Yaping Yang, Wei Wu, et al.. (2017). Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status. PLoS ONE. 12(5). e0176417–e0176417. 6 indexed citations
19.
Li, Mengjiao, et al.. (2015). Systematic characterization of small GTPases gene family in the model medicinal mushroom Ganoderma lucidum.. Nanjing Nongye Daxue xuebao. 38(6). 923–929. 2 indexed citations
20.
Su, Zhi, et al.. (2014). The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems. Human Vaccines & Immunotherapeutics. 10(3). 628–639. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanyuan Meng Breakdown of academic impact, for papers by Qing Yuan Breakdown of academic impact, for papers by Cheng Ni Breakdown of academic impact, for papers by Beibei Ni Breakdown of academic impact, for papers by Ke Yuan
Rankless by CCL
2026